Company profile
Molecular Partners
Pioneering DARPin Therapeutics for Patients
- Industry
- Biotechnology Research
- Employees
- 147
- Headquarters
- Schlieren-Zürich, Zürich Area
- Founded
- 2004
- LinkedIn followers
- 14,717
- Office locations
- 2
Molecular Partners company summary
Molecular Partners is a company in the Biotechnology Research industry, headquartered in Schlieren-Zürich, Zürich Area, founded in 2004. On LinkedIn the company has around 147 employees and 14,717 followers. The company lists 2 office locations. Its listed specialties include DARPins, Oncology, Immuno-Oncology, Radiopharmaceuticals, Immunology and other indications.
What technology does Molecular Partners use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Molecular Partners
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA.
Specialties
Where is Molecular Partners located?
Molecular Partners lists 2 office locations.
Compare companies similar to Molecular Partners
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Molecular Partners molecularpartners.com | Biotechnology Research | 147 | 2004 | Schlieren-Zürich, Zürich Area |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Molecular Partners
What does Molecular Partners do?
Molecular Partners AG is a clinical-stage biotech company pioneering the design and development of DARPin therapeutics, a new class of custom-built drugs for medical challenges other modalities cannot readily address. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. Molecular Partners leverages the advantages of DARPins to provide unique solutions to patients through its proprietary programs as well as through partnerships with leading pharmaceutical companies. Molecular Partners was founded in 2004 and has offices in both Zürich, Switzerland and Concord, MA, USA.
How many employees does Molecular Partners have?
Molecular Partners has around 147 employees on LinkedIn.
Where is Molecular Partners headquartered?
Molecular Partners is headquartered in Schlieren-Zürich, Zürich Area.
Where does Molecular Partners have offices?
Molecular Partners lists 2 office locations, including Schlieren-Zürich, Zürich Area, CH; West Concord, Massachusetts, US.
When was Molecular Partners founded?
Molecular Partners was founded in 2004.
Build a lead list from companies like Molecular Partners
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.